1974-2013年美国甲状腺癌发病率与死亡率趋势
基于SEER-9登记数据,分析1974-2013年甲状腺癌发病率和1994-2013年基于发病的死亡率趋势。共纳入77276例患者,甲状腺癌总体发病率年均增长3.6%,乳头状癌各分期发病率均上升,远处转移期乳头状癌死亡率年均增长2.9%。
要点
- 甲状腺癌总体发病率1974-2013年年均增长3.6%(95%CI 3.2%-3.9%)。
- 乳头状癌各SEER分期发病率均上升,远处转移期年均增长2.4%。
- 远处转移期乳头状癌基于发病的死亡率年均增长2.9%(95%CI 1.1%-4.7%)。
核心结论
- 1974-2013年美国甲状腺癌总体发病率年均增长3%,晚期乳头状癌发病率和死亡率均上升,提示甲状腺癌发生真实增加。
研究设计与样本
- 基于SEER-9癌症登记项目的趋势分析,纳入1974-2013年诊断的77276例甲状腺癌患者,平均诊断年龄48岁(SD 16),其中女性58213例(75%)。
主要发现
- 甲状腺癌发病率1974-2013年年均增长3.6%(95%CI 3.2%-3.9%),从1974-1977年的4.56/10万人年升至2010-2013年的14.42/10万人年。
- 乳头状癌年均增长4.4%(95%CI 4.0%-4.7%),局限期年均增长4.6%,区域期4.3%,远处转移期2.4%,未知分期1.8%。
- 1994-2013年基于发病的死亡率总体年均增长1.1%(95%CI 0.6%-1.6%),从1994-1997年的0.40/10万人年升至2010-2013年的0.46/10万人年。
- 远处转移期乳头状癌基于发病的死亡率年均增长2.9%(95%CI 1.1%-4.7%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Thyroid cancer incidence has increased substantially in the United States over the last 4 decades, driven largely by increases in papillary thyroid cancer. It is unclear whether the increasing incidence of papillary thyroid cancer has been related to thyroid cancer mortality trends. OBJECTIVE: To compare trends in thyroid cancer incidence and mortality by tumor characteristics at diagnosis. DESIGN, SETTING, AND PARTICIPANTS: Trends in thyroid cancer incidence and incidence-based mortality rates were evaluated using data from the Surveillance, Epidemiology, and End Results-9 (SEER-9) cancer registry program, and annual percent change in rates was calculated using log-linear regression. EXPOSURE: Tumor characteristics. MAIN OUTCOMES AND MEASURES: Annual percent changes in age-adjusted thyroid cancer incidence and incidence-based mortality rates by histologic type and SEER stage for cases diagnosed during 1974-2013. RESULTS: Among 77 276 patients (mean [SD] age at diagnosis, 48 [16] years; 58 213 [75%] women) diagnosed with thyroid cancer from 1974-2013, papillary thyroid cancer was the most common histologic type (64 625 cases), and 2371 deaths from thyroid cancer occurred during 1994-2013. Thyroid cancer incidence increased, on average, 3.6% per year (95% CI, 3.2%-3.9%) during 1974-2013 (from 4.56 per 100 000 person-years in 1974-1977 to 14.42 per 100 000 person-years in 2010-2013), primarily related to increases in papillary thyroid cancer (annual percent change, 4.4% [95% CI, 4.0%-4.7%]). Papillary thyroid cancer incidence increased for all SEER stages at diagnosis (4.6% per year for localized, 4.3% per year for regional, 2.4% per year for distant, 1.8% per year for unknown). During 1994-2013, incidence-based mortality increased 1.1% per year (95% CI, 0.6%-1.6%) (from 0.40 per 100 000 person-years in 1994-1997 to 0.46 per 100 000 person-years in 2010-2013) overall and 2.9% per year (95% CI, 1.1%-4.7%) for SEER distant stage papillary thyroid cancer. CONCLUSIONS AND RELEVANCE: Among patients in the United States diagnosed with thyroid cancer from 1974-2013, the overall incidence of thyroid cancer increased 3% annually, with increases in the incidence rate and thyroid cancer mortality rate for advanced-stage papillary thyroid cancer. These findings are consistent with a true increase in the occurrence of thyroid cancer in the United States.
引用
- Lim H, Devesa SS, Sosa JA, et al. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017. PMID: 28362912. doi:10.1001/jama.2017.2719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。